Funding
← Back to your selection

ICG

Activity from announced rounds

All recorded activity
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$141M
2 disclosed · full round size, not this investor’s share

By stage

Series B2

By primary sector

Biotech2

By country

United Kingdom1
United States1

Rounds

2 in all activity
Mediar Therapeutics

Develops therapies to halt fibrosis in multiple organ systems

$76MSeries B
Role not disclosed